>Mercado Europeu de Síndrome de Down, por tipo de doença (Trissomia 21, Síndrome de Down de Translocação , Síndrome de Down em Mosaico), Tratamento ( Diagnóstico , Terapêutica), Utilizador Final (Hospital, Clínicas, Ambiente de Homecare, Centros de Terapia, Outros), Canal de Distribuição (Concurso Directo, Comércio a Retalho, outros), país (Alemanha, Reino Unido, França, Itália, Espanha, Rússia, Polónia, Suíça, Países Baixos, Hungria, Áustria, Noruega, Irlanda, Turquia, Lituânia e resto da Europa) Tendências e previsões da indústria para 2028
Análise e insights de mercado: Mercado Europeu de Síndrome de Down
Espera-se que o mercado da síndrome de Down ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 13,78% no período de previsão de 2021 a 2028 e prevê-se que atinja os 725,12 milhões de dólares até 2028. O aumento da consciencialização sobre a doença e o aumento da prevalência da síndrome de Down são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.
Os avanços tecnológicos e o aumento do apoio governamental são os principais impulsionadores que impulsionaram a procura do mercado da síndrome de Down no período de previsão.
A síndrome de Down é uma doença genética que ocorre devido a uma divisão celular anormal. A divisão celular anormal provoca um ganho de cópia extra total ou parcial do cromossoma número 21. A presença de material genético extra provoca alterações físicas e de desenvolvimento entre as pessoas que levam à síndrome de Down. A anomalia genética mais comum associada à síndrome de Down inclui deficiências mentais, principalmente dificuldades de aprendizagem nas crianças.
A sensibilização permitiu que estas pessoas optassem por novas abordagens de diagnóstico juntamente com terapias avançadas, de modo a estabelecer um estilo de vida saudável. Isto significa, portanto, que a crescente consciencialização sobre a doença está a funcionar como motor para o crescimento do mercado da síndrome de Down . As complicações significam que a indisponibilidade de qualquer tratamento específico atua como uma restrição para o crescimento do mercado da síndrome de Down . Os players do mercado que operam no mercado da síndrome de Down estão a adotar diversas iniciativas estratégicas que deverão impulsionar os seus negócios em diversas dimensões, atuando como uma oportunidade para o crescimento do mercado da síndrome de Down . O longo tempo de aprovação associado ao lançamento do produto funciona como um desafio para o crescimento do mercado da síndrome de Down .
The Down syndrome market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Down syndrome market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Down Syndrome Market Scope and Market Size
The Down syndrome market is segmented on the basis of disease type, treatment, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disease type, the Down syndrome market is segmented into trisomy 21, translocation Down syndrome and mosaic Down syndrome. In 2021, trisomy 21 segment is dominating the market as more than 95 percent of cases of Down syndrome are trisomy 21.
- On the basis of treatment, the Down syndrome market is segmented into diagnosis and therapy. In 2021, diagnosis segment is dominating the market as most of the parents undertake prenatal tests to understand the condition of the fetus.
- On the basis of end user, the Down syndrome market is segmented into hospital, clinics, homecare setting, therapy centers and others. In 2021, hospital segment is dominating the market because they are the primary establishments for prenatal testing.
- On the basis of distribution channel, the Down syndrome market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is dominating in the market as it is the primary mode of purchase of diagnostic products by hospitals and clinics.
Down Syndrome Market Country Level Analysis
Down syndrome market is analyzed and market size information is provided by the country, disease type, treatment, end user and distribution channel as referenced above.
The countries covered in the Down syndrome market report are the Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, and Rest of Europe.
Europe is expected to grow with the highest CAGR in the forecast period as the diagnosis of Down syndrome is a routine test in most countries. Germany is expected to dominate in the market in the Europe market. Germany is one of the leading countries which have huge market potential in Europe and higher demand for Down syndrome diagnosis.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Government Support and Increasing Research and Development are Boosting the Market Growth of Down syndrome
Down syndrome market also provides you with detailed market analysis for every country growth in Down syndrome industry with Down syndrome drugs sales, impact of advancement in the Down syndrome technology and changes in regulatory scenarios with their support for the Down syndrome market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Down syndrome Market Share Analysis
Down syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Down syndrome market.
The major companies which are dealing in the Down syndrome are F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Abbott, Natera, Inc, AtilaBiosystems, Physio.co.uk, Novus Biologicals (a subsidiary of Bio-Techne), Down Syndrome Cork, a branch of Down Syndrome Ireland, Demeditec Diagnostics GmbH, Symbol, ASDclinic.co.uk among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Down syndrome market.
For instance,
- In April 2017, Illumina, Inc. launched VeriSeq NIPT solution in Europe. The product launched is a CE-IVD marked next-generation sequencing technology-based approach used for screening of chromosomal abnormalities and proved efficacious for providing accurate information about chromosomal status within 10 weeks of gestation. This product launch boosted the company’s product portfolio and allowed it to penetrate its root in worldwide Down syndrome market.
A colaboração, o lançamento de produtos, a expansão do negócio, a premiação e o reconhecimento, as joint ventures e outras estratégias do player de mercado estão a potenciar o mercado da empresa no mercado da síndrome de Down, o que também oferece o benefício para a organização melhorar a sua oferta para a síndrome de Down.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE Down syndrome MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- treatment of Down syndrome LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET END USER COVERAGE GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Europe DOWN SYNDROME MARKET: Pipeline analysis
- PIPELINE PRODUCTS IMPACT ANALYSIS
- NNI-351
- ASPARAGINASE
- ANVS-401
- QUILLIVANT XR
- TOFACITINIB
- MEMANTINE HYDROCHLORIDE
- NICOTINE
- AEF0217
- ACI-24
- Europe DOwn syndrome Market: Laws and regulations
- Market Overview
- Drivers
- increasing prevalence OF DOWN syndrome
- rising demand of effective therapies
- rising awareness about the diseasE
- technological ADVANCEMENTS
- increasing government support
- RESTRAINTS
- UNAVAILABILITY OF any specific treatment
- Side Effects Associated With Down Syndrome Treatment Therapies
- high cost of diagnosis
- opportunities
- STRATEGIC INITIATIVES BY MARKET PLAYERS
- increasing research and development
- presence of pipeline therapies
- presence of reimbursement
- challenGes
- Lack of Skilled Proffessionals
- Long Process for Product Launch
- Transfer of COVID-19 Infections by Diagnostic Methods
- Impact of COVID-19 on Europe Down Syndrome Market
- Price Impact
- Impact on Supply Chain
- Impact on Demand
- Strategic Decisions for Manufacturers
- Conclusion
- Europe Down syndrome MARKET, BY disease Type
- overview
- trisomy 21
- translocation Down syndrome
- mosaic Down syndrome
- Europe Down syndrome MARKET, BY treatment
- overview
- diagnosis
- Screening Tests
- First Trimester
- Blood Test
- Nuchal Translucency Testing
- Integrated Screening Test
- First Trimester
- Second Trimester
- The Triple Screen or Quadraple Screen Test
- Ultrasound
- Cell Free DNA
- Diagnostic Tests
- Chronic Villus Sampling
- Amniocentesis
- Precutaneous Umbical Cord Sampling
- therapy
- Early Intervention Therapy
- Speech-Language Therapy
- Physical Therapy
- Occupational Therapy
- Others
- Assistive Technology
- Hearing Aids
- Glasses
- Others
- Surgery
- Atrioventricular Septal Defect (AVSD)
- Duodenal Atresia
- Others
- Others
- Europe Down syndrome MARKET, BY end user
- overview
- hospital
- clinics
- homecare setting
- others
- Europe Down syndrome MARKET, BY distribution channel
- overview
- direct tender
- retail sales
- others
- EUROPE Down syndrome MARKET, by Geography
- europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Poland
- Switzerland
- Netherlands
- Hungary
- Austria
- Norway
- Ireland
- Turkey
- Lithuania
- Rest of Europe
- Europe Down syndrome market: COMPANY landscape
- company share analysis: Europe
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- Company ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- PerkinElmer Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Illumina, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Thermo Fisher Scientific Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Myriad Genetics, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Abnova Corporation
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ASDclinic.co.uk
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- AtilaBiosystems
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Boston Children's Hospital
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Boys Town National Research Hospital
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Children's Hospital Colorado
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Demeditec Diagnostics GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Down Syndrome Cork
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Mayo Clinic Health System
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Natera, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Next Biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Novus Biologicals (A Subsidiary of Bio-Techne)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Kid Sense Child Development Corporation Pty Ltd
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- Physio.co.uk.
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- Symbol
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Lista de Tabela
TABLE 1 Europe Down syndrome market: Pipeline Analysis
TABLE 2 REGULATION imposed by several regulatory agencies in different regions
TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)
TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)
TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)
TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
Lista de Figura
FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION
FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION
FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS
FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID
FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Europe Down syndrome market: SEGMENTATION
FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market
FIGURE 15 Europe Down syndrome market: BY disease type, 2020
FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)
FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)
FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE
FIGURE 1 Europe Down syndrome market: BY treatment, 2020
FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).
FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)
FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE
FIGURE 5 Europe Down syndrome market: BY end user, 2020
FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)
FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)
FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE
FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020
FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)
FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE
FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)
FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)
FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)
FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)
FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)
FIGURE 18 Europe Down syndrome market: company share 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.